Tatva
TATVA.NSTatva Chintan Pharma Chem Limited Price (TATVA.NS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
22,889,189
(3.267)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Tatva Chintan Pharma Chem LimitedCurrency: INR
| YEAR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
1,337,000,000.00
+0% |
2,024,490,000.00
+51% |
2,576,850,000.00
+27% |
2,968,570,000.00
+15% |
4,312,930,000.00
+45% |
4,236,120,000.00
-2% |
3,904,950,000.00
-8% |
||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 1,015,410,000.00 | 1,163,010,000.00 | 1,384,400,000.00 | 1,554,660,000.00 | 2,076,780,000.00 | 2,261,010,000.00 | 3,204,270,000.00 | ||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
321,590,000.00
+0% |
861,480,000.00
+168% |
1,192,450,000.00
+38% |
1,413,910,000.00
+19% |
2,236,150,000.00
+58% |
1,975,110,000.00
-12% |
700,680,000.00
-65% |
||||||||||||
| Gross Profit Ratio | (0.24%) | (0.43%) | (0.46%) | (0.48%) | (0.52%) | (0.47%) | (0.18%) | ||||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 1,890,000.00 | 1,990,000.00 | 10,140,000.00 | 2,790,000.00 | 37,070,000.00 | 60,390,000.00 | 79,420,000.00 | ||||||||||||
| General and Administrative | 0.00 | 39,530,000.00 | 22,740,000.00 | 22,930,000.00 | 43,840,000.00 | 50,670,000.00 | 58,900,000.00 | ||||||||||||
| Selling, General & Admin... | 132,620,000.00 | 198,740,000.00 | 192,970,000.00 | 214,810,000.00 | 382,100,000.00 | 404,760,000.00 | 219,260,000.00 | ||||||||||||
| Selling & Marketing Exp... | 0.00 | 159,210,000.00 | 170,230,000.00 | 191,880,000.00 | 338,260,000.00 | 287,660,000.00 | 225,130,000.00 | ||||||||||||
| Depreciation and Amortiz... | 29,520,000.00 | 40,180,000.00 | 47,930,000.00 | 67,320,000.00 | 81,800,000.00 | 95,550,000.00 | 256,050,000.00 | ||||||||||||
| Other Expenses | -2,040,000.00 | 390,000.00 | 453,130,000.00 | 4,500,000.00 | 1,330,000.00 | 57,440,000.00 | 0.00 | ||||||||||||
| Total Operating Expenses | 136,550,000.00 | 541,050,000.00 | 656,240,000.00 | 807,890,000.00 | 1,228,220,000.00 | 1,464,850,000.00 | 642,470,000.00 | ||||||||||||
| Cost and Exponses | 1,151,960,000.00 | 1,704,060,000.00 | 2,040,640,000.00 | 2,362,550,000.00 | 3,305,000,000.00 | 3,725,860,000.00 | 3,506,730,000.00 | ||||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
185,040,000.00
+0% |
317,000,000.00
+71% |
532,500,000.00
+68% |
601,810,000.00
+13% |
1,004,840,000.00
+67% |
584,690,000.00
-42% |
422,170,000.00
-28% |
||||||||||||
| Operating Income Ratio | (0.14%) | (0.16%) | (0.21%) | (0.20%) | (0.23%) | (0.14%) | (0.11%) | ||||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 0.00 | 2,710,000.00 | 5,170,000.00 | 3,590,000.00 | 45,490,000.00 | 41,590,000.00 | 23,960,000.00 | ||||||||||||
| Interest Expenses | 19,380,000.00 | 32,980,000.00 | 37,520,000.00 | 39,850,000.00 | 42,320,000.00 | 84,040,000.00 | 61,510,000.00 | ||||||||||||
| Total Other Income/Exp... | 5,300,000.00 | -46,500,000.00 | -60,240,000.00 | -546,350,000.00 | -923,590,000.00 | -131,560,000.00 | 13,510,000.00 | ||||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 245,960,000.00 | 353,390,000.00 | 566,190,000.00 | 717,710,000.00 | 1,169,630,000.00 | 626,960,000.00 | 756,710,000.00 | ||||||||||||
| EBITDA ratio | (0.16%) | (0.17%) | (0.22%) | (0.24%) | (0.27%) | (0.16%) | (0.19%) | ||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 190,340,000.00 | 273,930,000.00 | 475,970,000.00 | 606,960,000.00 | 1,041,210,000.00 | 447,790,000.00 | 435,680,000.00 | ||||||||||||
| Income Before Tax Ratio | (0.14%) | (0.14%) | (0.18%) | (0.20%) | (0.24%) | (0.11%) | (0.11%) | ||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 67,450,000.00 | 68,500,000.00 | 98,080,000.00 | 84,340,000.00 | 82,470,000.00 | -7,080,000.00 | 132,139,999.00 | ||||||||||||
| Net Income | |||||||||||||||||||
| Net Income | 122,890,000.00
+0% |
205,430,000.00
+67% |
377,890,000.00
+84% |
522,620,000.00
+38% |
958,740,000.00
+83% |
454,870,000.00
-53% |
303,540,000.00
-33% |
||||||||||||
| Net Income Ratio | (0.09%) | (0.10%) | (0.15%) | (0.18%) | (0.22%) | (0.11%) | (0.08%) | ||||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 6.12 | 10.23 | 18.81 | 26.02 | 44.59 | 20.52 | 13.26 | ||||||||||||
| Diluted EPS | 6.12 | 10.23 | 18.81 | 26.02 | 44.59 | 20.52 | 13.26 | ||||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 20,087,500.00 | 20,087,500.00 | 20,087,500.00 | 20,087,500.00 | 21,499,104.00 | 22,165,062.00 | 22,891,402.00 | ||||||||||||
| Diluted Share Outstanding | 20,087,500.00 | 20,087,500.00 | 20,087,500.00 | 20,087,500.00 | 21,499,104.00 | 22,165,062.00 | 22,889,189.00 | ||||||||||||